180 related articles for article (PubMed ID: 26221316)
21. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
Kim KS; Oh HJ; Kim DJ; Kim SK; Park SW; Cho YW; Huh KB
Endocr J; 2013; 60(12):1295-301. PubMed ID: 24047563
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque.
Yu LY; Hu KC; Liu CJ; Hung CL; Bair MJ; Chen MJ; Wang HY; Wu MS; Shih SC; Liu CC
Medicine (Baltimore); 2019 Mar; 98(9):e14672. PubMed ID: 30817593
[TBL] [Abstract][Full Text] [Related]
23. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
[TBL] [Abstract][Full Text] [Related]
24. Nonalcoholic fatty liver disease and carotid atherosclerosis in children.
Pacifico L; Cantisani V; Ricci P; Osborn JF; Schiavo E; Anania C; Ferrara E; Dvisic G; Chiesa C
Pediatr Res; 2008 Apr; 63(4):423-7. PubMed ID: 18356751
[TBL] [Abstract][Full Text] [Related]
25.
Zhao W; Mori H; Tomiga Y; Tanaka K; Perveen R; Mine K; Inadomi C; Yoshioka W; Kubotsu Y; Isoda H; Kuwashiro T; Oeda S; Akiyama T; Zhao Y; Ozaki I; Nagafuchi S; Kawaguchi A; Aishima S; Anzai K; Takahashi H
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886046
[TBL] [Abstract][Full Text] [Related]
26. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta-analysis.
Zhou YY; Zhou XD; Wu SJ; Fan DH; Van Poucke S; Chen YP; Fu SW; Zheng MH
Hepatol Commun; 2018 Apr; 2(4):376-392. PubMed ID: 29619417
[TBL] [Abstract][Full Text] [Related]
28. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
Targher G; Bertolini L; Padovani R; Poli F; Scala L; Zenari L; Zoppini G; Falezza G
J Endocrinol Invest; 2006 Jan; 29(1):55-60. PubMed ID: 16553034
[TBL] [Abstract][Full Text] [Related]
29. Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study.
Lankarani KB; Mahmoodi M; Lotfi M; Zamiri N; Heydari ST; Ghaffarpasand F; Fallahzadeh MK; Babaeinejad M; Maharlouei N; Mirzaee O; Geramizadeh B; Peymani P
Korean J Gastroenterol; 2013 Dec; 62(6):344-51. PubMed ID: 24365733
[TBL] [Abstract][Full Text] [Related]
30. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
[TBL] [Abstract][Full Text] [Related]
31. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.
Tang ASP; Chan KE; Quek J; Xiao J; Tay P; Teng M; Lee KS; Lin SY; Myint MZ; Tan B; Sharma VK; Tan DJH; Lim WH; Kaewdech A; Huang D; Chew NW; Siddiqui MS; Sanyal AJ; Muthiah M; Ng CH
Clin Mol Hepatol; 2022 Jul; 28(3):483-496. PubMed ID: 35232007
[TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.
Sinn DH; Cho SJ; Gwak GY; Cho J; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW
Medicine (Baltimore); 2016 Jan; 95(3):e2578. PubMed ID: 26817915
[TBL] [Abstract][Full Text] [Related]
34. Elevated Serum Gamma-glutamyl Transpeptidase Levels and Fatty Liver Strongly Predict the Presence of Carotid Plaque.
Toshikuni N; Asaji T; Nakanishi Y; Nagasawa SY; Uenishi H; Tsutsumi M
J Atheroscler Thromb; 2015; 22(10):1051-60. PubMed ID: 25891209
[TBL] [Abstract][Full Text] [Related]
35. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.
Ampuero J; Gallego-Durán R; Romero-Gómez M
Rev Esp Enferm Dig; 2015 Jan; 107(1):10-6. PubMed ID: 25603326
[TBL] [Abstract][Full Text] [Related]
36. Association between non-alcoholic fatty liver disease and ischemic stroke.
Moshayedi H; Ahrabi R; Mardani A; Sadigetegad S; Farhudi M
Iran J Neurol; 2014 Jul; 13(3):144-8. PubMed ID: 25422733
[TBL] [Abstract][Full Text] [Related]
37. Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study.
Castaldo L; Laguzzi F; Strawbridge RJ; Baldassarre D; Veglia F; Vigo L; Tremoli E; de Faire U; Eriksson P; Smit AJ; Aubrecht J; Leander K; Pirro M; Giral P; Ritieni A; Di Minno G; Mälarstig A; Gigante B
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33105679
[TBL] [Abstract][Full Text] [Related]
38. A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease.
Mishra S; Yadav D; Gupta M; Mishra H; Sharma P
Indian J Clin Biochem; 2013 Jan; 28(1):79-83. PubMed ID: 24381427
[TBL] [Abstract][Full Text] [Related]
39. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Wang CC; Lin SK; Tseng YF; Hsu CS; Tseng TC; Lin HH; Wang LY; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1411-6. PubMed ID: 19702910
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]